Tuberculosis Diagnostics Market

how will the tuberculosis diagnostics market l.w
1 / 3
Embed
Share

Projecting a $3.56 billion valuation by 2031, the Tuberculosis Diagnostics Market will grow at a 5% CAGR from 2024. Key factors driving this expansion include rising TB incidence in less affluent countries, drug-resistant TB strains, and supportive d


Uploaded on | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. How Will the Tuberculosis Diagnostics Market Reach $3.56 Billion by 2031?

  2. Tuberculosis Diagnostics Market 2024-2031 The tuberculosis diagnostics market is on a promising growth trajectory, expected to reach $3.56 billion by 2031, according to the latest report by Meticulous Research . This growth, forecasted at a CAGR of 5% from 2024 to 2031, is driven by the rising incidence of tuberculosis (TB) in low- and middle-income countries, the emergence of drug-resistant strains, and supportive initiatives for TB diagnosis and treatment. Governments and organizations are also amplifying efforts to raise awareness, creating significant growth opportunities for market players. Request For Sample Report: https://www.meticulousresearch.com/request-sample- report/cp_id=5885? Key Players and Their Impact Prominent players in the tuberculosis diagnostics market include F. Hoffmann-La Roche Ltd. (Switzerland), Becton, Dickinson and Company (U.S.), Abbott Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN GmbH (Germany), Hologic, Inc. (U.S.), bioM rieux SA (France), Danaher Corporation (U.S.), Oxford Immunotec Ltd. (U.K.), Hain Lifescience GmbH (Germany), and Creative Diagnostics (U.S.). These companies are crucial in driving innovations and advancements in tuberculosis diagnostics. Market Segmentation and Insights The market is segmented by test type, infection stage, end user, and geography. By test type, the market includes skin tests, radiographic tests, molecular tests, sputum smear microscopy, culture & drug resistance tests, and other methods. In 2024, skin tests (Mantoux) are expected to dominate with a 38.2% share due to their simplicity, low cost, and widespread availability, especially in remote areas. The infection stage segmentation distinguishes between active and latent TB. The active TB segment is projected to grow at the highest CAGR during the forecast period, driven by rising TB cases in lower-income countries and increased governmental and organizational efforts to manage TB. Regarding end users, diagnostic laboratories are anticipated to exhibit the highest CAGR. This growth is due to their capacity to implement advanced technologies like next-generation sequencing, which are often beyond the reach of smaller clinics and hospitals. Regional Outlook Geographically, the Asia-Pacific region is expected to witness the highest CAGR. India and China, in particular, present significant opportunities for growth due to their large Page 1 of 2 Meticulous Research| sales@meticulousresearch.com

  3. Tuberculosis Diagnostics Market 2024-2031 populations, high TB burden, and increasing healthcare investments. These factors are expected to drive demand for advanced diagnostic tools and technologies in these countries. Buy Now: https://www.meticulousresearch.com/Checkout/14457940? About Meticulous Research Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to detail. With meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 2 of 2 Meticulous Research| sales@meticulousresearch.com

Related